The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration

Transplantation

Volumn 69, Issue 2, 2000, Pages 285-293

  Motoyama, Kentaro ^a   Arima, Takeshi ^a   Yu, Samuel ^a   Lehmann, Manfred ^b   Flye, M Wayne ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; OKT 4;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; GRAFT REJECTION; HEART GRAFT; HELPER CELL; IMMUNOLOGICAL TOLERANCE; KIDNEY GRAFT; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN GRAFT; SPLEEN CELL; T LYMPHOCYTE; THYMECTOMY;

EID: 0034719360     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001270-00015     Document Type: Conference Paper

References (41)

1. Parnes JR. Molecular biology and function of CD4 and CD8. Adv Immunol 1989; 44: 265.
2. Fleury S, Lamarre D, Meloche S, et al. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 1991; 66: 1037.
3. Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ. The biologic roles of CD2, CD4, and CD8 in T cell activation. Annu Rev Immunol 1989; 7: 579.
4. Quill H, Schwartz RH. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 1987; 138: 3704.
5. Waldmann H. Manipulation of T-cell responses with monoclonal antibodies. Annu Rev Immunol 1989; 7: 407.
6. Benjamin RJ, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449.
7. Madsen JC, Peugh WN, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44: 849.
8. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988; 46(2 suppl): 128S.
9. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pre-transplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
10. Shizuru JA, Gregory AK, Chao CT, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
11. Waldor MK, Sriram S, Hardy R., et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T cell subset marker. Science 1985; 227: 415.
12. Wofsy D, Seaman WE. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol 1987; 138: 3247.
13. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T helper lymphocytes. Science 1988; 240: 659.
14. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990; 20: 2747.
15. Bushel A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995; 25: 2463.
16. Horneff G, Emmrich F, Reiter C, Kalden JR, Burmester GR. Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy. J Rheumatol 1992; 19: 1845.
17. van der Lubbe PA, Reiter C, Breedveld FC, et al. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthritis Rheum 1993; 36: 1375.
18. Tak PP, van der Lubbe PA, Cauli A, et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995; 38: 1457.
19. Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term follow-up of CD4+ T cell counts. Arthritis Rheum 1994; 37: 834.
20. Arima T, Lehmann M, Flye, MW. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Transplantation 1997; 63: 284.
21. Lehmann M, Sternkopf F, Metz F, et al. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992;54:959.
22. Siegling A, Lehmann M, Riedel H, et al. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
23. Onodera K, Lehmann M, Akalin E, et al. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157: 1944.
24. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
25. Fabre J, Lim SH, Morris PJ. Renal transplantation in the rat: details of a technique. Aust N Z J Surg 1971; 41: 69.
26. Savas CP, Nolan MS, Lindsey NJ, Boyle PF, Slater DN, Fox M. Renal transplantation in the rat: a new simple, non-suture technique. Urol Res 1985; 13: 91.
27. Billingham R, Medawar P. The technique of free skin grafting in mammals. Br J Exp Biol 1952; 28: 385.
28. Gallimore PH. Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA in nine lines of transformed rat cells using specific fragments of the viral genome. J Mol Biol 1974; 89: 49.
29. Bellgrau D. Induction of cytotoxic T cell precursors in vivo role of T helper cells. J Exp Med 1983; 157: 1505.
30. Langrehr JM, Dull KE, Ochoa JB, et al. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 1992; 53: 632.
31. Burkhardt K, Charlton B, Mandel TE. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine. Transplantation 1989; 47: 771.
32. Darby CR, Morris PJ, Wood KJ. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Transplantation 1992; 54: 483.
33. Binder J, Lehmann M, Graser E, et al. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 1996; 61: 804.
34. Ramsdell F, Fowlkes BJ. Maintenance of in vivo tolerance by persistence of antigen. Science 1992; 257: 1132.
35. Eianello PR, Biancho G, Fishbein JF, et al. Mechanism of cyclosporine-induced tolerance to primarily vascularized allografts in miniature swine: effect of administration of exogenous IL-2. J Immunol 1994; 153: 4788.
36. Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. Transplantation 1994; 58: 133.
37. Williams ME, Shea CM, Lichtman AH, Abbas AK. Antigen receptor-mediated anergy in resting T lymphocytes and T cell clones. Correlation with lymphokine secretion patterns. J Immunol 1992; 149: 1921.
38. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145: 3796.
39. Steinmuller D, Wachtel SS. Transplantation biology and immunogenetics of murine skin-specific (Sk) alloantigens [Review]. Transplant Proc 1980; 12: 100.
40. Heath WR, Hurd ME, Carbone FR, Sherman LA. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature 1989; 341: 749.
41. Poindexter NJ, Naziruddin B, McCourt DW, Mohanakumar T. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J Immunol 1995; 154: 3880.